Education
PhD Candidate, University of Cambridge
BS, University of Wisconsin–Madison
Caroline Zellmer, PhD, is a Senior Program Manager and works on early therapeutic development across companies at Foresite Labs.
Most recently, Caroline led 3 large industrial-academic therapeutic development collaborations (large and small molecule) at the University of Cambridge, including one with GSK where she also was a Visiting Scientist.
Prior to Cambridge, Caroline developed microbial therapeutics for malnutrition and diarrheal diseases. During this time, Caroline also held joint positions as a Research Affiliate and Visiting Lecturer at MIT.
Caroline started her career investigating emerging infectious diseases at the US NIH. Caroline received her bachelor’s degree with honors in research at the University of Wisconsin–Madison, where she studied Microbiology, History of Science, and Global Health. She later completed graduate training at the Institut Pasteur, Paris and received her PhD from the University of Cambridge, where she developed novel therapeutics for drug resistant pathogens.
In a volunteer capacity, Caroline serves on the Microbiology Society’s advisory board. Her work has been published in the New England Journal of Medicine and cited in the IDSA clinical treatment guidelines for C. difficile infection.